These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17578540)

  • 1. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
    Brandes JL; Smith T; Diamond M; Ames MH
    Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
    Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
    Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
    Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
    Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naratriptan in the short-term prophylaxis of pure menstrual migraine.
    Moschiano F; Allais G; Grazzi L; Usai S; Benedetto C; D'Amico D; Roncolato M; Bussone G
    Neurol Sci; 2005 May; 26 Suppl 2():s162-6. PubMed ID: 15926020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oral naratriptan in the treatment of menstrually related migraine.
    Massiou H; Jamin C; Hinzelin G; Bidaut-Mazel C;
    Eur J Neurol; 2005 Oct; 12(10):774-81. PubMed ID: 16190915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group.
    Bomhof MA; Heywood J; Pradalier A; Enahoro H; Winter P; Hassani H
    Cephalalgia; 1998 Jan; 18(1):33-7. PubMed ID: 9601622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Naratriptan Long-Term Study Group.
    Heywood J; Bomhof MA; Pradalier A; Thaventhiran L; Winter P; Hassani H
    Cephalalgia; 2000 Jun; 20(5):470-4. PubMed ID: 11037743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study.
    Sheftell FD; Rapoport AM; Tepper SJ; Bigal ME
    Headache; 2005; 45(10):1400-6. PubMed ID: 16324173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
    Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
    Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD; Elkind AH; Schreiber C; Keywood C
    Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
    Wade A; Pawsey S; Whale H; Boyce M; Warrington S
    Clin Drug Investig; 2009; 29(5):325-37. PubMed ID: 19366274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group.
    Klassen A; Elkind A; Asgharnejad M; Webster C; Laurenza A
    Headache; 1997; 37(10):640-5. PubMed ID: 9439085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute treatment and prevention of menstrually related migraine headache: evidence-based review.
    Pringsheim T; Davenport WJ; Dodick D
    Neurology; 2008 Apr; 70(17):1555-63. PubMed ID: 18427072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.